Could A Blood Test Help Detect Pancreatic Cancer?
Blood-based biomarkers may help scientists identify pancreatic cancer at an early stage, a new study found—a significant finding that could help patients receive treatment...
Lynparza Approved for Advanced Pancreatic Cancer
The Food and Drug Administration granted approval for AstraZeneca and Merck’s Lynparza (olaparib) as a first-line maintenance therapy in adult patients with germline BRCA-mutated...
Pancreatic Cancer Treatment and Tumor Biology Differences by Race
A new study explored outcomes in pancreatic ductal adenocarcinoma by race, questioning whether treatment inequity, tumor biology, or both contribute to poorer outcomes among...
Classifying Pancreatic Cancer Tumors May Improve Treatment Options
The findings of a new study may help predict resistance to treatments for pancreatic cancer. The study was published in the journal Clinical Cancer...
Colorectal and Pancreatic Cancer Rates Have Increased in the Past 30 Years
A large study spanning 195 countries found that colorectal and pancreatic cancer rates have increased by 10% between 1990 and 2017, according to a...
Researchers Identify New Approach to Administering Cancer Radiation
Researchers from Osaka University and the University of Heidelberg are experimenting with a new approach to radiation therapy that may effectively treat pancreatic cancer...
Triplet Pancreatic Cancer Regimen Demonstrates “Encouraging” Survival
The addition of cisplatin to Abraxane® (nab-paclitaxel) and Gemzar® (gemcitabine) improved survival in patients with pancreatic cancer, according to a study published in JAMA...
